Skip to main content

Advertisement

Fig. 3 | Journal of Translational Medicine

Fig. 3

From: The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort

Fig. 3

Additional gene expression signatures associated with clinical benefit of anti-PD-1 in NSCLC. a Forest plot of difference of multi-gene signature scores between responders and non-responders in the NSCLC cohort. The position of the squared dots denotes the difference of score, and the size denotes the statistical significance. The horizontal lines are the Wald-type confidence intervals. The * sign denotes the significance of p-value (< 0.001***, < 0.01**, < 0.05*). b The Spearman correlation matrix between the signature scores was calculated for the signatures that showed significant difference in the differential expression analysis between responder and non-responders

Back to article page